RESEARCH-USE BIOSIMILAR ANTIBODY

Boserolimab

Monoclonal antibody · Not specified

TNFRSF7Not specifiedRUO

Boserolimab (MK-5890) is a humanized agonist monoclonal antibody that binds to CD27 to provide a costimulatory signal that enhances T-cell–mediated responses.

TARGETTNFRSF7
YMonoclonal antibody
CATALOGSC-BS-706
CATALOG NUMBERSC-BS-706
MOLECULAR WEIGHTApprox. 144.91 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Boserolimab (MK-5890) is a humanized agonist monoclonal antibody that binds to CD27 to provide a costimulatory signal that enhances T-cell–mediated responses.

Boserolimab is a recombinant research-use antibody directed against TNFRSF7.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Boserolimab | StellaCyte